| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,458,000 | 3,236,000 | 4,191,000 | 3,546,000 | | Cost of Revenue | 2,138,000 | (1,651,000) | 2,884,000 | 2,401,000 | | | Gross Profit | 1,320,000 | 4,887,000 | 1,307,000 | 1,145,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 197,000 | 4,108,000 | 189,000 | 191,000 | | Non Recurring | (9,000) | (2,000) | (6,000) | (5,000) | | Others | 382,000 | 360,000 | 387,000 | 373,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 750,000 | 421,000 | 737,000 | 586,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,000 | 44,000 | 47,000 | 52,000 | | Earnings Before Interest And Taxes | 764,000 | 464,000 | 782,000 | 638,000 | | Interest Expense | 222,000 | 288,000 | 216,000 | 234,000 | | Income Before Tax | 542,000 | 176,000 | 566,000 | 404,000 | | Income Tax Expense | 179,000 | 34,000 | 192,000 | 123,000 | | Minority Interest |
-
| (2,000) | (3,000) | (1,000) | | | | Net Income From Continuing Ops | 363,000 | 141,000 | 374,000 | 280,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 11,000 |
-
| 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 363,000 | 152,000 | 374,000 | 281,000 | | Preferred Stock And Other Adjustments | (3,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $360,000 | $152,000 | $374,000 | $281,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
